Entropy Technologies’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05M Buy
+97,369
New +$873K 0.03% 586
2025
Q2
– Sell
-29,739
Closed -$191K – 950
2025
Q1
$191K Buy
+29,739
New +$246K 0.02% 634
2024
Q4
– Sell
-12,499
Closed -$158K – 913
2024
Q3
$158K Buy
+12,499
New +$161K 0.02% 656

Other funds holding NVAX

Entropy Technologies's NVAX Position: Q3 2026 in Review

Entropy Technologies opened a new position in Novavax (NVAX) in Q3 2026: 97,369 shares worth $1.05M. The stake represents 0.03% of the portfolio and ranks #586 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in NVAX as recently as Q1 2025.

Entropy Technologies first reported a position in NVAX in Q3 2024 and has held it in 3 quarters since. 260 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Entropy Technologies held 97,369 shares of Novavax worth $1.05M as of Q3 2026.
  • Novavax was a new Entropy Technologies position in Q3 2026.
  • Novavax made up 0.03% of Entropy Technologies's portfolio in Q3 2026, its #586 holding.
  • Entropy Technologies first reported a position in Novavax in Q3 2024 and has held it in 3 quarters since.
  • 260 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.